NFE2L2 and colitis: The results showed that the beneficial effects of ME on DSS-induced colitis were reduced by ML385 pretreatment (Figures 1B–F), indicating that ME could alleviate the severity of DSS-induced chronic colitis via Nrf2 pathway activation.